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L abour is induced in 1 of 5 births 1,2 for maternal reasons (e.g., preeclampsia, cardiac or renal disease), fetal reasons (e.g., intrauterine growth restriction) or a combination (e.g., poorly controlled diabetes, preterm rupture of the membranes or post-term pregnancy). 3 Induction of labour artificially ripens the cervix and initiates uterine contractions in wo men who are not already in labour, leading to progressive dilation of the cervix to achieve vaginal birth of a baby at any gestation beyond the legal definition of fetal viability. 4 Although induction of labour has been criticized for an associated increased risk of cesarean delivery, recent studies have shown that there are fewer cesarean deliveries with induction than without it. However, the findings have not had much impact on practice, in part because the systematic reviews [5] [6] [7] [8] investigated subsets of induction and included few randomized controlled trials (RCTs), and because observational data in a cohort study 9 had risk of confounding. Consumer organizations, 10 guidelines 11 and textbooks 12, 13 have given contradictory information about cesarean risk, which can lead to confusion over decision-making, particularly given a desire to support normal birth in the face of increasing cesarean rates worldwide. Cesarean delivery carries multiple risks to mother and baby, including maternal death, 14 infection and postnatal depression, 15, 16 and respiratory distress syndrome in neonates.
14 Accurate, precise information about cesarean risk is therefore needed for decision-making regarding labour induction.
We conducted a systematic review and metaanalysis of RCTs to investigate the risk of cesarean delivery associated with labour induction compared with expectant management. We also explored the effects of clinical characteristics and study quality on the overall result using subgroup and meta-regression analyses.
Methods

Data sources and study selection
In April 2012, we searched the electronic databases MEDLINE, Embase, CAB Abstracts, CENTRAL (the Cochrane Central Register of Controlled Trials) and Science Citation Index (accessed via Web of Science) for eligible RCTs using the search terms and word variants for the concept "labour induction" and "cesarean delivery." The search strategy is outlined in Appendix 1 (available at www.cmaj.ca/lookup/suppl /doi:10.1503 /cmaj.130925/-/DC1). The Cochrane Database of Systematic Reviews was also searched for primary trials. Titles and abstracts of all citations were assessed for inclusion by 2 of 3 reviewers (C.M., E.R. or E.M.). Disagreements were resolved through consensus with input from the third reviewer.
We included RCTs if they recruited pregnant women carrying a viable fetus, they compared an active induction with placebo or expectant management (hereafter referred to as expectant management), and they reported rates of cesarean delivery as one of the outcomes. Methods of active intervention included mechanical methods (amniotomy, membrane sweeping, Foley catheter insertion with or without extra-amniotic saline infusion), use of pharmacologic agents (prostaglandins, oxytocin, corticosteroids, mifepristone, estrogens, relaxin, misoprostol, isosorbide mononitrate) and alternative methods (acupuncture, breast stimulation, sexual intercourse, homeopathic preparations, castor oil, bath, enema). We excluded RCTs that recruited women who had a multiple pregnancy or were in active labour, those in which an active intervention was applied in the control group or within 12 hours after randomization and trials in which the control group comprised women in spontaneous labour. No restrictions were applied to year, language or publication status.
Data extraction and quality assessment Two of us (E.R. and E.M.) independently extracted the following data from the trials: method of induction, reason for induction, and number of cesarean and non cesarean (vaginal or instrumental) deliveries in the intervention and control groups, and information required to assess methodologic quality. Many of the efficacy or safety studies did not provide reasons for labour induction. If primary trials were inaccessible through online and library databases, we extracted information from the Cochrane Database of Systematic Reviews and contacted the authors of the trial to confirm the results.
For the assessment of methodologic quality, we evaluated the following parameters for risk of bias: sequence generation, allocation concealment, blinding of participants and personnel, and management of incomplete output data. 17 We did not assess blinding of participants and personnel in trials that used mechanical interventions because it cannot be applied in such situations.
Disagreements in grouping, coding or quality assessment were resolved through consensus with input from a third author (C.M. or K.S.K.).
Data synthesis
We assessed heterogeneity between trials by inspecting forest plots and using the I 2 statistic (I 2 values of 25%, 50% and 75% corresponded to cut-off points of low, moderate and high degrees of heterogeneity, respectively). 18 For the primary and subgroup analyses, we calculated pooled relative risk (RR) estimates and 95% confidence intervals (CIs) using random-effects models, with each study weighted according to inverse of variance. In a number of trials, some participants were lost to follow-up or were excluded from analyses for other reasons; we therefore used intention-to-treat denominators in the metaanalyses. In the subgroup meta-analyses, we investigated whether risk of cesarean delivery differed according to indication for labour induction, induction method, gestational age (term, preterm or post-term), definition of induction (cervical priming, induction of uterine contractions or both), cervical status (unfavourable or favourable), pregnancy risk (high or low) and parity (nulliparous or parous).
We used meta-regression analysis to explore whether patient characteristics (indication for induction, gestational age at induction, cervical score, pregnancy risk, parity), induction methods (type of intervention and definition of induction [cervical priming v. no cervical priming]) and study quality (random sequence generation, allocation concealment, performance bias and attrition bias) explained the heterogeneity. We also evaluated safety (in terms of maternal and fetal deaths, and admission to neonatal intensive care unit) and methods of induction currently used in clinical practice in the United Kingdom, Canada and the United States. 1, 2, 19 We used the Harbord modified test for small-study effects to examine publication bias in funnel plots.
We used Review Manager software (RevMan version 5.2; Nordic Cochrane Centre, Cochrane Collaboration, 2012) to conduct the meta-analyses and Stata software (Stata Statistical Software, release 11; StataCorp; 2009) to perform the meta-regression analyses.
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Results
We identified 2894 potentially relevant studies through the literature search. The selection of trials for our meta-analysis is summarized in Figure 1 . After the screening of titles and abstracts and removal of duplicate records, 215 articles were reviewed in full. We excluded 58 because they did not report rates of cesarean delivery (5 trials), the active intervention was applied in the control group (10) or within 12 hours after randomization (3), an incorrect allocation method was used (8), the control group included women in spontaneous labour (11) , the study had a nonrandomized design (11) , women in active labour were included at the time of randomization (9), or the trial included women with a multiple pregnancy (1 Figure 2 and shown for each trial in Appendix 4 (available at www.cmaj.ca/lookup /suppl/doi:10.1503/cmaj.130925/-/DC1).
The summary results of the primary and subgroup meta-analyses are shown in Figure 3 . Results for the individual trials are shown in Appendix 5 (available at www.cmaj.ca/lookup /suppl/doi:10.1503 /cmaj.130925/-/DC1). Overall, the risk of cesarean delivery was lower with labour induction than with expectant management (pooled RR 0.88, 95% CI 0.84-0.93). Statistical heterogeneity was low (I 2 = 0%). Nevertheless, planned meta-regression analysis to explain heterogeneity did not show a significant impact of variables on the main result (Appendix 6, available at www.cmaj.ca/lookup/suppl /doi:10.1503 /cmaj.130925/-/DC1). In particular, initial cervical score (p = 0.4), indication for induction (p = 0.8) and method of induction (p = 0.6) did not alter the main result. The test for publication bias was not significant (p = 0.5) (Appendix 7, available at www.cmaj.ca/lookup /suppl/doi:10.1503 /cmaj.130925/-/DC1).
In the subgroup analysis by method of induction (Figure 3 ), 4 methods were associated with a significant reduction in risk of cesarean deliv- Results from studies with low risk of bias related to allocation concealment were compatible with the main finding (RR 0.89, 95% CI 0.80-0.99, I 2 = 9%). Exclusion of induction methods not currently used in clinical practice in the UK, Canada and the US (relaxin, isosorbide mononitrate, mifepristone, cortico steroids and alternative methods described earlier in the meth-
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CMAJ, June 10, 2014, 186(9) ods) showed an effect comparable to the main result (RR 0.89, 95% CI 0.84-0.93; I 2 = 0%). Analysis of adverse outcomes showed a lower risk of fetal death and admission to neonatal intensive care unit associated with labour induction than with expectant management (Table 1) . No impact on maternal death was shown.
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Interpretation
Our meta-analysis showed that the risk of cesarean delivery following labour induction was significantly lower than the risk associated with expectant management. This finding supports evidence from systematic reviews [5] [6] [7] [8] but is contrary to prevalent beliefs and information from consumer organizations, guidelines and textbooks. [10] [11] [12] [13] Labour induction was associated with benefits for the fetus and no increased risk of maternal death.
Subgroup analysis by method of induction showed a significant reduction in risk of cesarean delivery associated with the use of prostaglandin E analogues (prostaglandin E2 and misoprostol). This is encouraging, since use of prostaglandin E2 is the main method of induction in the UK and the main method of cervical ripening in the US and Canada. 1, 2, 19 However, use of oxytocin and amniotomy, still widely practised induction methods, did not confer a benefit on cesarean delivery. In the subgroup analysis by indication for induction, mixed reason (maternal, fetal and obstetric) and post-dates pregnancy were associated with a reduced risk of cesarean delivery. In uncomplicated term pregnancies with no medical reason for induction provided, the risk of cesarean delivery was reduced by 19% on average. We also observed risk reductions associated with induction in term and post-term pregnancies and in high-and low-risk pregnancies. Our findings are important when selecting candidates for labour induction and when advising women on the risks of induction.
Limitations
Our study has limitations. We could not retrieve and verify 4 primary studies and therefore had to use numeric data obtained from the Cochrane Database of Systematic Reviews. However, the reliance on these data likely did not have much effect on the results because our analysis including the remaining 153 studies was sufficiently powerful for reliable inferences. When we updated our searches in February 2014, we found 336 new citations published since April 2012. Of these, only 2 trials 177,178 met our inclusion criteria. The number of participants in the trials was 636, which represented 2% of the total in our current analysis. Both studies concluded that there was no effect on cesarean delivery rates with relative imprecision, so our main conclusion remains robust.
We restricted our analyses to RCTs with appropriate sequence generation, minimizing the risk of bias and confounding. Concealment of allocation was reported unclearly in half of the studies, risking bias in both the clinical management of the women and the assessment of outcomes. However, studies with a low risk of bias in allocation concealment supported the main finding.
We explored many potential confounding factors but did not account for all. For example, body mass index and maternal age may be associated with increased rates of complication. We could not always disentangle reasons for induction and had to lump together maternal, fetal and obstetric indications, leading to some difficulty in interpretation.
We included studies dating from 1975 to 2010; therefore, differences in practice over this time period may have influenced the findings. These issues would be best addressed in a metaanalysis of individual patient data.
Although 2 of us abstracted the study data independently, errors in coding may have occurred and thus are a potential source of bias. This is especially true for the definition of induction and assessment of pregnancy risk, because these parameters were not always defined in detail in the primary studies and had to be judged.
Conclusion
Our meta-analysis has provided a robust answer to the disputed question of risk of cesarean delivery associated with induction of labour. Women whose labour was induced were less likely than those managed expectantly to have a cesarean delivery. In addition, the risk of fetal death and admission to neonatal intensive care unit were decreased in the induction group. Our findings have implications for guidelines and the practice of obstetrics, and are reassuring for mothers, midwifes and obstetricians. Note: CI = con dence interval, NICU = neonatal intensive care unit.
